The antibacterial paradox: Essential drugs, effectiveness, and cost

Bulletin of the World Health Organization

Volumn 77, Issue 3, 1999, Pages 211-216

  Fasehun, F ^a,b  

^a World Health Organization ^*  (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; BENZATHINE PENICILLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FURAN DERIVATIVE; GENTAMICIN; LINCOSAMIDE DERIVATIVE; METRONIDAZOLE; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; SULFADIMIDINE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNINDEXED DRUG;

DRUG PRESCRIBING; HEALTH CARE; WORLD HEALTH ORGANIZATION;

AFRICA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG LEGISLATION; DRUG UTILIZATION; ECUADOR; ESTONIA; HEALTH CARE UTILIZATION; HONDURAS; PHILIPPINES; SOUTHEAST ASIA; WORLD HEALTH ORGANIZATION; YEMEN;

ADULT; ANTI-INFECTIVE AGENTS; DRUG COSTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION REVIEW; DRUGS, ESSENTIAL; HEALTH POLICY; HUMANS; WORLD HEALTH;

EID: 0032975140     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. MacInnes R, Lumley CE, Walker SR. New chemical entity output of the international pharmaceutical industry from 1970 to 1992. Clinical pharmacology and therapeutics, 1994, 56: 339-349.
2. The world drug situation. Geneva, World Health Organization, 1988.
3. Antal GM, Mehus A. Sexually transmitted diseases in developing countries. Current opinion in infectious diseases, 1988, 1: 26-32.
4. Tomasz A. Multiply resistant pathogenic bacteria: a report on the Rockefeller University workshop. New England journal of medicine, 1994, 330: 1247-1251.
5. Model prescriber information on sexually transmitted diseases and HIV. Geneva, World Health Organization, 1995.
6. The use of essential drugs. Model list of essential drugs. Seventh report of the WHO Expert Committee. Geneva, World Health Organization, 1997 (WHO Technical Report Series, No. 867).
7. Botswana drug catalogue and treatment guide. Gaborone, Botswana National Standing Committee on Drugs, 1995.
8. The Kenyan essential drugs list. Nairobi, Ministry of Health, 1993.
9. Malawi standard drug list. Lilongwe, Ministry of Health/Malawi Essential Drugs Programme, 1991.
10. Federal Republic of Nigeria essential drugs list. Abuja, Federal Ministry of Health, 1989.
11. Essential drugs list for Zimbabwe including guidelines for treatment of medical conditions common in Zimbabwe. Harare, Ministry of Health, 1989.
12. République du Bénin liste nationale des médicaments essentiels sous noms génériques. Porto-Novo, Ministère de la Santé, 1994.
13. Liste des médicaments essentiels en dénomination de Mali. Bamako, Ministère de la Santé Publigue et des Affaires Sociales, 1990.
14. Liste nationale des médicaments essentiels. In: Formulaire national des médicaments. Conakry, République de Guinée, Ministèrede la Santé, 1992.
15. Cuadro nacionalde medicamentos bâsicos, 2nd ed. Consejo Nacional de Salud, Comisión Nacional de Farmacología, 1992 (in Spanish).
16. Lista de medicamentos básicos. Tegucigalpa, República de Honduras, Secretaría de Salud Pública. Ministerio de Salud Pública in collaboration with WHO/PAHO, 1993 (in Spanish).
17. People 's Democratic Republic of Yemen essential drugs list and Eastern Mediterranean drug information sheets. Ministry of Health, 1990.
18. List of essential drugs for Estonia. Tallinn, Ministry of Health, 1992.
19. National list of essential drugs of Bhutan. Thimphu, Royal Government Directorate of Health Services, 1995.
20. List of essential drugs, first revision. Colombo, Ministry of Health of Sri Lanka, 1988.
21. Thailand national list of essential drugs. Bangkok, National Drug Committee, Ministry of Health, 1992.
22. Philippines national drug formulary, 2nd ed, Essential drugs list. Manila, National Drug Committee Department of Health, 1990.
23. The management of acute respiratory infections in children. Practical guidelines for outpatient care. Geneva, World Health Organization, 1995.
24. The management and prevention of diarrhoea. Practical guidelines, 3rd ed. Geneva, World Health Organization, 1993.
25. Shaw PR, Griffin CC. Financing health care in sub-Saharan Africa through user fees and insurance. Washington, DC, World Bank, 1995.
26. La-Ruche G, Lorougnon F, Digbeu N. Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Côte d'Ivoire: assessment of efficacy and cost. Bulletin of the World Health Organization, 1995, 73: 305-313.
27. Gomo E et al. In vitro activity of several antimicrobial agents against Neisseria gonorrhoeae and comparison of cost of treatment. Central African journal of medicine, 1995, 41: 83-86.
28. Williams JD. Quo vadis with bacterial resistance. Drugs, 1995, 49: 1-9.
29. Vandepitte J et al. Guidelines for antimicrobial resistance surveillance. Alexandria, WHO Regional Office for the Eastern Mediterranean, 1996.
30. Michel M, Gutmann L. Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet, 1997, 349: 1901-1906.